Draftfcb Acquires Hudson Global; Aligns It With Draftfcb Healthcare
NEW YORK, Sept. 12, 2012 /PRNewswire/ — Draftfcb, the global marketing communications agency network that is part of the Interpublic Group (NYSE: IPG), is acquiring Hudson Global, a Tarrytown, N.Y.-based pharmaceutical marketing company that offers integrated marketing solutions encompassing the entire pharmaceutical brand management spectrum, and aligning it under its Draftfcb Healthcare umbrella. The merger will create a top 5 healthcare offering in the U.S.
“Our acquisition of Hudson is part of a long-term plan to make strategic acquisitions that will bolster our clients’ businesses and strengthen our agency’s offerings in those markets that offer the greatest opportunity,” said Laurence Boschetto, global CEO and president of Draftfcb.
Hudson Global, with 55+ employees, includes among its core services: digital media and interactive marketing programs, peer-to-peer programming, consumer programming, medical strategy, and data and analytics services. It also has an important educational component that is aimed at professional healthcare, patient, and consumer audiences.
Since its founding in 2004, Hudson has provided solutions to sales and marketing teams at more than 30 pharma companies and represented more than 60 different pharmaceutical brands, which generate over $46 billion in annual sales.
Hudson currently works with three types of clients: pharma, diagnostic and biotech. It provides services to 20 major companies, including 15 of the largest pharma companies in the world. The company also works with mid-tier pharma companies and medical device companies. Hudson operates in a variety of therapeutic areas including oncology, cardiovascular, CNS, dermatology, diabetes, gastroenterology, infectious diseases, pediatrics, respiratory, rheumatology, women’s health, and biologics.
Hudson will retain its name, and maintain its Tarrytown location. It will continue to be led by Robert Blink, co-founder and CEO/President of Hudson, and Jason Goldklang, co-founder and Executive Vice President. Blink will report directly to Draftfcb Healthcare and Draftfcb New York CEO Dana Maiman.